Assignee
CERENO SCIENT AB
SE·5 granted patents·7 pending applications·0 citations·filing 2015–2025
Top patents by PatentIndex Score
12 records- 0173US12245999B2Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2022·Granted Mar 11, 2025·0 cites·17 claims
- 0268US2023094176A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsCERENO SCIENT AB·Filed 2022·Application pending·0 cites
- 0367US12023311B2Delayed release pharmaceutical formulations comprising valproic acid, and uses thereofCERENO SCIENT AB·Filed 2022·Granted Jul 2, 2024·0 cites·22 claims
- 0466US2025241880A1Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2025·Application pending·0 cites
- 0565US2023364089A1Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2023·Application pending·0 cites
- 0664US11400064B2Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2018·Granted Aug 2, 2022·0 cites·9 claims
- 0762US2025066282A1Novel analogs of valproic acid and methods of medical treatment using the sameCERENO SCIENT AB·Filed 2022·Application pending·0 cites
- 0859US2021060014A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsCERENO SCIENT AB·Filed 2020·Application pending·0 cites
- 0955US10111845B2Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2015·Granted Oct 30, 2018·0 cites·24 claims
- 1052US11395808B2Delayed release pharmaceutical formulations comprising valproic acid, and uses thereofCERENO SCIENT AB·Filed 2017·Granted Jul 26, 2022·0 cites·18 claims
- 1147US2020179381A1Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formationCERENO SCIENT AB·Filed 2017·Application pending·0 cites
- 1245US2017020874A1Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitorsCERENO SCIENT AB·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CERENO SCIENT AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →